The Department of Medical Oncology (Division IV) at the First Affiliated Hospital of Zhejiang University School of Medicine is a comprehensive oncology diagnosis and treatment center integrating chemotherapy, targeted therapy, immunotherapy, endocrine therapy, and combined traditional Chinese and Western medicine. Upholding the model of "daytime hospital treatment, nighttime home recovery," the department enables patients to receive treatment in a comfortable manner. Based on ensuring medical safety and through comprehensive management and care throughout the cancer treatment process, we provide convenient, high-quality, efficient, patient-centered, and multidisciplinary medical services to cancer patients.

Our department consists of 12 physicians and 16 nurses, many of whom have gained national and international recognition for their clinical and/or research efforts.

1. Efficient and Convenient Day Clinic + Inpatient Model: Patients can receive treatment at the hospital's "Day Clinic Center" according to their chemotherapy schedule, then return home to enjoy a "normal life" and the warmth of their families. Day treatment is more convenient, and the day clinic or inpatient arrangement can be flexibly adjusted based on the patient's condition.

2. Cross-Campus Day Clinic + Inpatient Services at Yuhang and Chengzhan Campuses: Choose the campus most convenient for you.

3. Rigorous and Scientific Multidisciplinary Diagnosis and Treatment (MDT): Through discussions among multidisciplinary experts, we provide optimal treatment plans for cancer patients.

4. Cutting-Edge Cancer Immunotherapy: We offer the latest international treatment options, including PD-1/PD-L1 inhibitors, CAR-T therapy, oncolytic virus clinical trials, and more.

5. More Choices Through Clinical Research: As one of the leading clinical research centers for new drugs in China, cancer patients in our department will have access to more opportunities for new drug treatments.

Building upon the strengths of Zhejiang University and the First Affiliated Hospital of Zhejiang University School of Medicine, our department specializes in thoracic, urological, and gastrointestinal tumors. We have initiated and participated in numerous international and domestic multicenter clinical studies, with some research outcomes contributing to updates in clinical guidelines. At the same time, the department has established long-term and stable partnerships with internationally leading medical centers, including MD Anderson Cancer Center, UCLA Health hospitals, and Stanford Medicine, among others. Additionally, we have developed a comprehensive translational research system that bridges basic science and clinical practice, enabling cutting-edge international technologies to be applied in clinical settings as early as possible, thereby benefiting cancer patients sooner.

Leveraging these foundations, our team has secured multiple grants from the National Natural Science Foundation and the Provincial Natural Science Foundation, published several SCI-indexed papers (with the highest impact factor reaching 30.840), and contributed to the compilation of multiple authoritative medical texts published by People's Medical Publishing House.